CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...